EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

How omics is revealing new roles for glia in addiction

David J Bergkamp iD, John F Neumaier iD

Glia · 2025

DOI: 10.1002/glia.24584 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Glia, 2025. Verfasst von David J Bergkamp und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Neuroglia, Substance-Related Disorders, Metabolomics, Genomics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Experiments to study the biology of addiction have historically focused on the mechanisms through which drugs of abuse drive changes in the functioning of neurons and neural circuits. Glia have often been ignored in these studies, however, and this has left many questions in the field unanswered, particularly, surrounding how glia contribute to changes in synaptic plasticity, regulation of neuroinflammation, and functioning of neural ensembles given massive changes in signaling across the CNS. Omics methods (transcriptomics, translatomics, epigenomics, proteomics, metabolomics, and others) have expanded researchers' abilities to generate hypotheses and carry out mechanistic studies of glial cells during acquisition of drug taking, intoxication, withdrawal, and relapse to drug seeking. Here, we present a survey of how omics technological advances are revising our understanding of astrocytes, microglia, oligodendrocytes, and ependymal cells in addiction biology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeurogliaSubstance-Related DisordersMetabolomicsGenomicsHumansAnimalsProteomics

Stichwörter der Autor:innen

alcoholastrocytescocainemicrogliaoligodendrocytesomicsopioid

Autor:innen und Institutionen

  • Department of Pharmacology, University of Washington, Seattle, Washington, USA.
  • VISN 20 Mental Illness Research, Education and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington, USA.
  • Department of Psychiatry & Behavioral Sciences, University of Washington, Seattle, Washington, USA.

ORCID-Profile: David J Bergkamp, John F Neumaier

Förderung

  • NIDA NIH HHS
  • National Institute on Drug Abuse

Zitieren

APA

Bergkamp, D. J., & Neumaier, J. F. (2025). How omics is revealing new roles for glia in addiction. Glia. https://doi.org/10.1002/glia.24584

Vancouver

Bergkamp DJ, Neumaier JF. How omics is revealing new roles for glia in addiction. Glia. 2025. doi:10.1002/glia.24584

BibTeX
@article{Bergkamp2025,
  author = {Bergkamp, David J and Neumaier, John F},
  title = {How omics is revealing new roles for glia in addiction},
  journal = {Glia},
  year = {2025},
  doi = {10.1002/glia.24584}
}
Kostenlos starten →